GLP-1R Antagonist Antibodies for Rare Metabolic Diseases, Primed for Development

Tap Into Twist Biopharma’s Robust Antibody Pipeline

ADORA2A Antagonist Antibodies for Immuno-Oncology, Primed for Development

SARS-CoV-2 Spike S1 Antagonist Antibodies for COVID-19, Primed for Clinical Development

GLP-1R Agonist Antibodies for Weight Management, Primed for Clinical Development

Antibody Development: From Target to Molecule

Accelerate Your Discovery Efforts with Twist Antibody Libraries

Developing Therapeutics Against Virtually Any Target with New Antibody Libraries

A Semi-Synthetic Human Hyperimmune Antibody Library for Drug Discovery

Hyperimmune Library

Synthetic DNA Technologies Enable Fast & Responsive Antibody Discovery & Optimization

Human Monoclonal Antibodies for SARS-CoV-2 S1

Human Monoclonal Antibodies for Human ACE2

Human Monoclonal Antibody Panel for Human ACE2 Protein

Twist Biopharma Brochure